Threshold Haemoglobin Levels and the Prognosis of Stable Voronary Disease: Two New Cohorts and a Systematic Review and Meta-Analysis

PLoS Medicine

Volumn 8, Issue 5, 2011, Pages

  Shah, Anoop D ^a,b   Nicholas, Owen ^a   Timmis, Adam D ^c   Feder, Gene ^d   Abrams, Keith R ^e   Chen, Ruoling ^f   Hingorani, Aroon D ^a   Hemingway, Harry ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANGINA PECTORIS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SURVIVAL; SYSTEMATIC REVIEW; ELECTRONIC MEDICAL RECORD; KAPLAN MEIER METHOD; MIDDLE AGED; RISK FACTOR; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; COHORT STUDIES; ELECTRONIC HEALTH RECORDS; FEMALE; GREAT BRITAIN; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79958012898     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000439     Document Type: Review

References (53)

1. Weiss G, Goodnough LT, (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
2. Abrams J, (2005) Clinical practice. Chronic stable angina. N Engl J Med 352: 2524-2533.
3. van der Meer P, Groenveld H, Januzzi JL, van Veldhuisen D, (2009) Erythropoietin treatment in patients with chronic heart failure: a meta-analysis. Heart 95: 1309-1314.
4. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, et al. (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032.
5. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098.
6. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, et al. (2005) Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111: 2042-2049.
7. Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, et al. (2004) Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 43: 2009-2014.
8. Hemingway H, Riley RD, Altman DG, (2009) Ten steps towards improving prognosis research. BMJ 339: b4184.
9. Reinecke H, Trey T, Wellmann J, Heidrich J, Fobker M, et al. (2003) Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24: 2142-2150.
10. Ennezat PV, Lamblin N, Mouquet F, Tricot O, Quandalle P, et al. (2008) The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction. Eur Heart J 29: 1992-1999.
11. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ, (2010) Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 69: 4-14.
12. Hammad TA, McAdams MA, Feight A, Iyasu S, Dal Pan G, (2008) Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 17: 1197-1201.
13. NHS Information Authority (2009) The clinical terms version 3 (The Read Codes). Available: http://www.connectingforhealth.nhs.uk/systemsandservices/data/readcodes/index_html. Accessed 22 April 2010.
14. NHS Information Centre (2007) The quality and outcomes framework. Available: http://www.ic.nhs.uk/statistics-and-data-collections/audits-and-performance/the-quality-and-outcomes-framework. Accessed 22 April 2010.
15. Lewis JD, Brensinger C, (2004) Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf 13: 437-441.
16. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266.
17. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, et al. (2004) New ICD-10 version of the Charlson Comorbidity Index predicted in-hospital mortality. J Clin Epidemiol 57: 1288-1294.
18. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, et al. (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362: 800-811.
19. Sung L, Hayden J, Greenberg ML, Koren G, Feldman BM, et al. (2005) Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol 58: 261-268.
20. Robins JM, Greenland S, (1986) The role of model selection in causal inference from nonexperimental data. Am J Epidemiol 123: 392-402.
21. Grambsch P, Therneau T, (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-5.
22. R Development Core Team (2009) R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 3-900051-07-0 Available: http://www.R-project.org. ISBN.
23. Hemingway H, Henriksson M, Chen R, Damant J, Fitzpatrick N, et al. (2010) The effectiveness and cost effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model. Health Technol Assess 14.
24. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
25. Lumley T, (2009) The rmeta package: meta-analysis. Available: http://CRAN.R-project.org/package=rmeta. Accessed 22 April 2010.
26. Lipsic E, Asselbergs FW, van der Meer P, Tio RA, Voors AA, et al. (2005) Anaemia predicts cardiovascular events in patients with stable coronary artery disease. Neth Heart J 13: 254.
27. da Silveira AD, Ribeiro RA, Rossini AP, Stella SF, Ritta HA, et al. (2008) Association of anemia with clinical outcomes in stable coronary artery disease. Coron Artery Dis 19: 21-26.
28. Fathi RB, Gurm HS, Chew DP, Gupta R, Bhatt DL, et al. (2005) The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention. Am Heart J 150: 1190-1197.
29. Rajagopal V, Gurm HS, Bhatt DL, Lincoff AM, Tcheng JE, et al. (2004) Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. Am J Cardiol 94: 190-192.
30. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, et al. (2006) Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97: 993-996.
31. Exaire JE, Butman SM, Ebrahimi R, Kleiman NS, Harrington RA, et al. (2006) Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Am Heart J 152: 157-163.
32. Burr ML, Holliday RM, Fehily AM, Whitehead P, (1992) Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J 13: 166-170.
33. Muzzarelli S, Pfisterer M, (2006) Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J 152: 991-996.
34. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
35. Kilpatrick GS, Hardisty RM, (1961) The prevalence of anaemia in the community. a survey of a random sample of the population. Br Med J 1: 778-782.
36. World Health Organisation (1968) Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405: 5-37.
37. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JWR, et al. (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164: 982-988.
38. Di Angelantonio E, Danesh J, Eiriksdottir G, Gudnason V, (2007) Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review. PLoS Med 4: e270 doi:10.1371/journal.pmed.0040270.
39. Gagnon DR, Zhang TJ, Brand FN, Kannel W, (1994) Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J 127: 674-682.
40. Danesh J, Collins R, Peto R, Lowe G, (2000) Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 21: 515-520.
41. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, et al. (2006) Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 166: 1380-1388.
42. Curtis KK, Pruthi RK, Fonseca R, Gornet M, (2007) Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic prostate cancer. Urology 70: 811.
43. Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, et al. (2008) Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 93: 914-919.
44. Metivier F, Marchais SJ, Guerin AP, Pannier B, London G, (2000) Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant 15 (Suppl 3): 14-18.
45. Ezekowitz JA, McAlister FA, Armstrong PW, (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107: 223-225.
46. Tang YD, Katz SD, (2006) Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 113: 2454-2461.
47. Geisler B, (2010) Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents. Expert Opin Biol Ther 10: 1209-1216.
48. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, et al. (2006) Anemia, chronic renal disease and congestive heart failure-the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 38: 295-310.
49. Meal AG, Pringle M, Hammersley V, (2000) Time changes in new cases of ischaemic heart disease in general practice. Fam Pract 17: 394-400.
50. Angelantonio ED, Sarwar N, Perry P, Kaptoge S, et al. Emerging Risk Factors Collaboration (2009) Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302: 1993-2000.
51. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, et al. (2006) Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27: 1341-1381.
52. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, et al. (2005) Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 16: 2180-2189.
53. van Veldhuisen DJ, McMurray JJ, (2007) Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. Eur J Heart Fail 9: 110-112.